Carulli Michael — SEC Form 4 filings
SEC reporting owner CIK 2006668. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-09.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-22 to 2026-03-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 31,140 shares, $34,424 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 28,249 shares @ $1.06 ($30,077) in PMV Pharmaceuticals, Inc., filed 2025-07-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | Chief Financial Officer | 6 | — | 2 legs · 31,140 sh · $34,424 | 9 |
Form 4 filings — Carulli Michael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-09 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Sale (S): 28,249 @ $1.06 | EDGAR |
| 2025-03-05 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/award (A): 265,000 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Disposition to issuer (D): 13,605 (derivative) · Disposition to issuer (D): 27,200 (derivative) · Grant/award (A): 40,805 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Grant/award (A): 75,000 (derivative) | EDGAR |
| 2024-09-12 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Sale (S): 2,891 @ $1.50 | EDGAR |
| 2024-01-22 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/award (A): 82,220 @ $0 · Grant/award (A): 204,630 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2006668 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →